FDA-approved indications for hyperbaric oxygen therapy
Hyperbaric oxygen therapy is approved for the treatment of the following conditions. Our team evaluates each patient to develop a customized treatment protocol.
Hyperbaric oxygen promotes healing in chronic diabetic wounds by enhancing oxygen delivery to compromised tissues.
Treatment addresses delayed radiation injuries by stimulating new blood vessel growth in damaged tissues.
Enhanced oxygen levels help fight refractory osteomyelitis by boosting the body's immune response.
Rapid displacement of carbon monoxide from hemoglobin helps prevent delayed neurological complications.
Oxygen therapy accelerates healing in wounds that have not responded to standard treatments.
Pressurized oxygen reduces swelling and helps prevent tissue death following traumatic crush injuries.
Hyperbaric oxygen is toxic to the anaerobic bacteria that cause gas gangrene, supporting surgical treatment.
Enhanced oxygenation supports survival and integration of skin grafts and flaps.
Treatment reduces edema and promotes healing in severe burn injuries.
The primary treatment for decompression sickness, reducing nitrogen bubbles in the bloodstream.
Pressurization reduces the volume of gas bubbles and promotes their reabsorption.
Early treatment with hyperbaric oxygen may improve outcomes in idiopathic sudden hearing loss.
